Sr. Manager of Regulatory Affairs Cmc

Eli Lilly Eli Lilly · Pharma · Bei Jing-北京, China

This role is for a Sr. Manager of Regulatory Affairs CMC at Eli Lilly, focusing on new product registrations and life-cycle maintenance from a Chemistry, Manufacturing, and Controls (CMC) perspective. The individual will drive CMC strategy, prepare dossiers, oversee testing, manage queries, and shape the regulatory environment in China. It requires deep technical expertise in CMC drug development and compliance, with a strong understanding of China's regulations and ICH guidelines.

What you'd actually do

  1. Independently manage project registrations and daily regulatory work
  2. Actively gather intelligence, participate and shape regulatory environment, especially as an SME
  3. Contribute to team responsibilities including RA SOPs, task forces and other ad hoc initatives
  4. Provide deep technical expertise in CMC area
  5. Ensure compliance with company policies, principles & procedures which China local team is trained on these aspects.

Skills

Required

  • Master degree in pharmaceutical or chemical/biopharmaceutical sciences
  • At least >7 years experience in drug development or regulatory affairs
  • At least 3-year experience in global leading pharmaceutical company
  • Hands-on experience of full NDA/BLA project from submission to approval
  • Familiar with China regulation and ICH guidance
  • Good skill on English speaking, listening and writing
  • Demonstrated communication and influence skills
  • Problem-solving skills
  • Ability to work within a global and cross-function team
  • Self-motivated
  • Innovative

Nice to have

  • Knowledge of regulations and guidelines of FDA and EMA regulation and guidelines
  • For biological group candidates, deep knowledge of biological products development and registration
  • An experience of ADC, gene or cell therapy is preferred
  • For chemical group candidates, experience with novel therapeutic modalities is a plus
  • Experience with synthetic peptides, SiRNA and Radio Ligand products

What the JD emphasized

  • CMC strategy development
  • dossier preparation
  • overseeing QC testing
  • managing query response
  • SME role
  • shape regulatory environment
  • new product registration
  • life-cycle maintenance
  • CMC strategy
  • CMC risks
  • mitigation plans
  • CMC documents
  • China specific CMC technical documents
  • key technical issues
  • China regulations and guidelines
  • CMC questions
  • global RA CMC
  • global CMC PM
  • global supply chain
  • China specific regulatory requirements
  • aligned CMC registration strategy
  • local cross-functional teams
  • CMC strategy
  • business growth
  • HA communication meeting materials
  • regulatory environment shaping activities
  • industry platforms
  • relevant regulations and guidelines
  • RA SOPs
  • task forces
  • ad hoc initatives
  • internal document templates
  • guidance and processes
  • ad-hoc projects
  • CMC drug development science
  • analytical techniques
  • DS and DP manufacturing
  • quality compliance system
  • SME
  • technical consultation
  • company policies, principles & procedures